Wichtige Publikationen seit 01.01.2007:
Henkenius Katharina, Greene Brandon H, Barckhausen Christina, Hartmann Raimo, Märken Melanie, Kaiser Tom, Rehberger Miriam, Metzelder Stephan K, Parak Wolfgang J, Neubauer Andreas, Brendel Cornelia, Mack Elisabeth. Maintenance of cellular respiration indicates drug resistance in acute myeloid leukemia.
Leukemia. 2017 Nov; 56-63.
Immunosuppressive capacity of mesenchymal stem cells correlates with metabolic activity and can be enhanced by valproic acid. Killer MC, Nold P, Henkenius K, Fritz L, Riedlinger T, Barckhausen C, Frech M, Hackstein H, Neubauer A, Brendel C.
Stem Cell Res Ther. 2017 Apr 26;8(1):100.
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML. Schütz C, Inselmann S, Sausslele S, Dietz CT, Mu Ller MC, Eigendorff E, Brendel CA, Metzelder SK, Bru Mmendorf TH, Waller C, Dengler J, Goebeler ME, Herbst R, Freunek G, Hanzel S, Illmer T, Wang Y, Lange T, Finkernagel F, Hehlmann R, Huber M, Neubauer A, Hochhaus A, Guilhot J, Xavier Mahon F, Pfirrmann M, Burchert A.
Leukemia. 2017 Apr;31(4):829-836.
Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs. Nold P, Hartmann R, Feliu N, Kantner K, Gamal M, Pelaz B, Hühn J, Sun X, Jungebluth P, Del Pino P, Hackstein H, Macchiarini P, Parak WJ, Brendel C.
J Nanobiotechnology. 2017 Mar 29;15(1):24.
A rational two-step approach to KRAS mutation testing in colorectal cancer using high resolution melting analysis and pyrosequencing. Mack E, Stabla K, Riera-Knorrenschild J, Moll R, Neubauer A, Brendel C.
BMC Cancer. 2016 Aug 2;16:585.
A Gain-Of-Function Mutation in the Plcg2 Gene Protects Mice from Helicobacter felis-Induced Gastric MALT Lymphoma. Gossmann J, Stolte M, Lohoff M, Yu P, Moll R, Finkernagel F, Garn H, Brendel C, Bittner A, Neubauer A, Huynh MQ.
PLoS One. 2016 Mar 11;11(3):e0150411.
Prospectively defined murine mesenchymal stem cells inhibit Klebsiella pneumoniae-induced acute lung injury and improve pneumonia survival. Hackstein H, Lippitsch A, Krug P, Schevtschenko I, Kranz S, Hecker M, Dietert K, Gruber AD, Bein G, Brendel C, Baal N.
Respir Res. 2015 Oct 6;16:123.
NFATc1 as a therapeutic target in FLT3-ITD-positive AML. Metzelder SK, Michel C, von Bonin M, Rehberger M, Hessmann E, Inselmann S, Solovey M, Wang Y, Sohlbach K, Brendel C, Stiewe T, Charles J, Ten Haaf A, Ellenrieder V, Neubauer A, Gattenlöhner S, Bornhäuser M, Burchert A.
Leukemia. 2015 Jul;29(7):1470-7.
Interferon alpha 2 maintenance therapy may enable high rates of treatment discontinuation in chronic myeloid leukemia. Burchert A, Saussele S, Eigendorff E, Müller MC, Sohlbach K, Inselmann S, Schütz C, Metzelder SK, Ziermann J, Kostrewa P, Hoffmann J, Hehlmann R, Neubauer A, Hochhaus A.
Leukemia. 2015 Jun;29(6):1331-5.
Oncogenic NRAS Primes Primary Acute Myeloid Leukemia Cells for Differentiation. Brendel C, Teichler S, Millahn A, Stiewe T, Krause M, Stabla K, Ross P, Huynh M, Illmer T, Mernberger M, Barckhausen C, Neubauer A.
PLoS One. 2015 Apr 22;10(4):e0123181.
Antithetical NFATc1-Sox2 and p53-miR200 signaling networks govern pancreatic cancer cell plasticity. Singh SK, Chen NM, Hessmann E, Siveke J, Lahmann M, Singh G, Voelker N, Vogt S, Esposito I, Schmidt A, Brendel C, Stiewe T, Gaedcke J, Mernberger M, Crawford HC, Bamlet WR, Zhang JS, Li XK, Smyrk TC, Billadeau DD, Hebrok M, Neesse A, Koenig A, Ellenrieder V.
EMBO J. 2015 Feb 12;34(4):517-30.
Immunosuppressive capabilities of mesenchymal stromal cells are maintained under hypoxic growth conditions and after gamma irradiation. Nold P, Hackstein H, Riedlinger T, Kasper C, Neumann A, Mernberger M, Fölsch C, Schmitt J, Fuchs-Winkelmann S, Barckhausen C, Killer M, Neubauer A, Brendel C.
Cytotherapy. 2015 Feb;17(2):152-62.
Collection of peripheral blood progenitor cells on Day 4 is feasible and effective while reducing granulocyte-colony-stimulating factor exposure to healthy donors. Flommersfeld S, Sohlbach K, Jaques G, Bein G, Hoffmann J, Kostrewa P, Sachs UJ.
Transfusion. 2015 Jun;55(6):1269-74.
Monitoring of acute myeloid leukemia patients after allogeneic stem cell transplantation employing semi-automated CD34+ donor cell chimerism analysis. Hoffmann JC, Stabla K, Burchert A, Volkmann T, Bornhäuser M, Thiede C, Neubauer A, Brendel C.
Ann Hematol. 2014 Feb;93(2):279-85.
Transcription factor IRF4 determines germinal center formation through follicular T-helper cell differentiation. Bollig N, Brüstle A, Kellner K, Ackermann W, Abass E, Raifer H, Camara B, Brendel C, Giel G, Bothur E, Huber M, Paul C, Elli A, Kroczek RA, Nurieva R, Dong C, Jacob R, Mak TW, Lohoff M.
Proc Natl Acad Sci U S A. 2012 May 29;109(22):8664-9.
Low BCR-ABL expression levels in hematopoietic precursor cells enable persistence of chronic myeloid leukemia under imatinib. Kumari A, Brendel C, Hochhaus A, Neubauer A, Burchert A.
Blood. 2012 Jan 12;119(2):530-9.
α4 integrin levels on mobilized peripheral blood stem cells predict rapidity of engraftment in patients receiving autologous stem cell transplantation. Hartz B, Volkmann T, Irle S, Loechelt C, Neubauer A, Brendel C.
Blood. 2011 Aug 25;118(8):2362-5.
Targeting p73 in cancer. Maas AM, Bretz AC, Mack E, Stiewe T.
Cancer Lett. 2013 May 28;332(2):229-36.
Evaluation of Aurora kinase inhibition as a new therapeutic strategy in anaplastic and poorly differentiated follicular thyroid cancer. Wunderlich A, Fischer M, Schlosshauer T, Ramaswamy A, Greene BH, Brendel C, Doll D, Bartsch D, Hoffmann S.
Cancer Sci. 2011 Apr;102(4):762-8.
Comparison of RNA yield from small cell populations sorted by flow cytometry applying different isolation procedures. Mack E, Neubauer A, Brendel C.
Cytometry A. 2007 Jun;71(6):404-9.
Imatinib mesylate and nilotinib (AMN107) exhibit high-affinity interaction with ABCG2 on primitive hematopoietic stem cells. Brendel C, Scharenberg C, Dohse M, Robey RW, Bates SE, Shukla S, Ambudkar SV, Wang Y, Wennemuth G, Burchert A, Boudriot U, Neubauer A.
Leukemia. 2007 Jun;21(6):1267-75.